ABSTRACT
BACKGROUND: We previously described a model of laser-induced thrombosis in mesenteric arterioles with superficial and deep levels of injury producing a transient thrombus resolving within 2 min and a larger almost occlusive thrombus, respectively. Both types of lesion were sensitive to platelet GPIIb-IIIa and P2Y(12) inhibition, whereas only deep injuries were sensitive to thrombin blockade. OBJECTIVE: The aim of the present study was to use histologic methods and electron and intravital microscopy to characterize the lesions and thrombi and to extend our knowledge of the sensitivity of this model to genetic and pharmacologic inhibition. RESULTS: A superficial injury was found to detach the endothelial cells and expose a collagen III- and IV-rich subendothelium where platelets could adhere. Tissue factor and fibrin were not detected. Deeper penetration of the external elastic lamina occurred in deep injuries, with exposure of collagen I, III and IV. Here the thrombus was composed of platelets exhibiting a decreasing gradient of degranulation from the deepest lesion area to the surface. Fibrin was found close to the most activated platelets. Consistently, glycoprotein VI (GPVI)-collagen and GPIb-von Willebrand factor (VWF) interactions were found to be critical in superficial injuries. After deep lesion, thrombus formation was modestly reduced in GPVI-immunodepleted mice and still strongly inhibited in VWF(-/-) mice. Combined hirudin infusion and GPVI depletion further inhibited thrombosis after deep injury. CONCLUSIONS: This study confirms the feasibility of inducing arterial thrombosis with distinct levels of severity and establishes the central roles of collagen and VWF in thrombus formation after superficial injury. Collagen, VWF and thrombin all appear to contribute to thrombosis after deep arterial lesion.
Subject(s)
Blood Platelets/ultrastructure , Endothelium, Vascular/ultrastructure , Mesenteric Arteries/ultrastructure , Mesenteric Vascular Occlusion/pathology , Platelet Adhesiveness , Thrombosis/pathology , Animals , Blood Platelets/drug effects , Blood Platelets/metabolism , Collagen Type I/metabolism , Collagen Type III/metabolism , Collagen Type IV/metabolism , Disease Models, Animal , Endothelium, Vascular/drug effects , Endothelium, Vascular/injuries , Endothelium, Vascular/metabolism , Feasibility Studies , Fibrin/metabolism , Fibrinolytic Agents/administration & dosage , Hirudins/administration & dosage , Injections, Subcutaneous , Lasers, Gas , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/injuries , Mesenteric Arteries/metabolism , Mesenteric Vascular Occlusion/blood , Mesenteric Vascular Occlusion/etiology , Mesenteric Vascular Occlusion/prevention & control , Mice , Mice, Knockout , Platelet Adhesiveness/drug effects , Platelet Membrane Glycoproteins/deficiency , Platelet Membrane Glycoproteins/metabolism , Severity of Illness Index , Thrombosis/blood , Thrombosis/etiology , Thrombosis/prevention & control , Time Factors , von Willebrand Factor/genetics , von Willebrand Factor/metabolismABSTRACT
OBJECTIVE: The platelet glycoprotein (GP)Ib-V-IX complex is a receptor required for normal hemostasis deficient in the Bernard-Soulier bleeding disorder. To evaluate the consequences of GPIb-V-IX deficiency in thrombosis we generated mouse models of the disease by targeting the GPIb beta subunit. METHODS AND RESULTS: Complete deletion (GPIb beta-/-) or an intracellular truncation (GPIb beta deltaIC-/-) reproduced typical and variant forms of Bernard-Soulier, with absent and partial (20%) expression of the complex on the platelet surface. Both strains exhibited thrombocytopenia and enlarged platelets with abnormal microtubular structures but normal granule composition. They exhibited prolonged tail bleeding times, which were less pronounced in GPIb beta deltaIC-/-. Decreased thrombus formation was observed after blood perfusion over a collagen coated surface at high shear. Resistance to vascular occlusion and an abnormal thrombus composition were observed in a model of FeCl3-induced lesion of carotid arteries. In a model of laser-induced lesion of mesenteric arterioles, thrombosis was strongly reduced in GPIb beta-/- mice, while a more modest effect was observed in GPIb beta deltaIC-/- animals. Finally, the two strains were protected against death in a model of systemic thromboembolism. CONCLUSIONS: This study provides in vivo evidence of a decreased thrombotic tendency linked to defective platelet GPIb-V-IX in mouse models of Bernard-Soulier syndrome.
Subject(s)
Bernard-Soulier Syndrome/complications , Platelet Glycoprotein GPIb-IX Complex/metabolism , Thrombosis/etiology , Thrombosis/prevention & control , Animals , Bernard-Soulier Syndrome/metabolism , Bernard-Soulier Syndrome/physiopathology , Blood Platelets/pathology , Blood Platelets/physiology , Collagen , Disease Models, Animal , Gene Expression Regulation , Hemostasis/genetics , Hemostasis/physiology , Mice , Mice, Knockout , Platelet Count , Platelet Glycoprotein GPIb-IX Complex/genetics , Thrombocytopenia/pathology , Thrombocytopenia/physiopathology , Thrombosis/metabolism , Thrombosis/physiopathologyABSTRACT
The role of the phospholipase C (PLC)gamma 2 isotype in platelet activation was evaluated by studying PLC gamma 2 -/- mice. These mice have a prolonged bleeding time but their platelets respond normally to non-collagenous agonists. PLC gamma 2-null platelets show residual aggregation response to collagen fibres (6% versus 74% for wild-type) with minimal granule secretion and no shape change. A delayed shape change is observed at later aggregation times. Specific activation by glycoprotein (GP)VI agonists (convulxin, collagen-related peptide and GPVI crosslinking) is, however, abolished. Antibodies against integrin alpha(2)beta(1) and GPVI each inhibit the residual collagen response, implying a role of alpha(2)beta(1) in platelet activation and a functional association with GPVI. These responses are also prevented by blocking integrin alpha(IIb)beta(3) and phosphoinositide 3-kinase, whereas aspirin treatment and ADP receptor blockade only inhibit shape change. These results provide evidence for a PLC gamma 2-independent collagen activation pathway requiring cooperation between GPVI and alpha(2)beta(1) leading to alpha(IIb)beta(3)-dependent aggregation and shape change by released ADP and thromboxane A(2).
